Composition

Marek’s Disease, HVT– Newcastle Disease (rHVT/NDV) at least 2 474 PFU through expiration Marek’s Disease, Rispens CVI -988 strain at least 1 206 PFU through expiration Preservatives: Gentamicin and Amphotericin B  

ATC Code/ATCvet Code

QI01AD21  

Product Category

Veterinary

Marketing Category

Prescription-only Medicine (POM)  

Packsize

2 mL x 1000 doses x 10's (in ampoules)  

Product Description

Lyophilized powder and solvent for injectable suspension. Combined live, cell-associated hatchery vaccine containing genetically engineered Marek's Disease vaccine of serotype 3 (Turkey Herpes Virus or HVT) expressing a Newcastle disease key protective antigen, and a serotype 1 (Rispens) Marek’s Disease Virus.

Manufacturer Name

Ceva Animal Health, LLC

Manufacturer Country

UNITED STATES OF AMERICA  

Approval Date

2025-05-27  

Expiry Date

2030-05-26